Thursday, 19 May 2016

Dishman Pharma Q4



Cons Net Profit At Rs.50 Cr Vs Rs.38.6 Cr (YoY)

 Cons Total Income At Rs.422.1 Cr Vs Rs.423.7 Cr (YoY)
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)